Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Accounts Payables (2020 - 2025)

BioAtla (BCAB) has 5 years of Accounts Payables data on record, last reported at $13.7 million in Q4 2024.

  • For Q4 2024, Accounts Payables rose 258.84% year-over-year to $13.7 million; the TTM value through Dec 2024 reached $13.7 million, up 258.84%, while the annual FY2024 figure was $13.7 million, 258.84% up from the prior year.
  • Accounts Payables reached $13.7 million in Q4 2024 per BCAB's latest filing, up from $2.9 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $24.9 million in Q3 2021 and bottomed at $2.5 million in Q4 2020.
  • Average Accounts Payables over 5 years is $10.0 million, with a median of $5.1 million recorded in 2023.
  • Peak YoY movement for Accounts Payables: soared 650.16% in 2021, then plummeted 85.18% in 2022.
  • A 5-year view of Accounts Payables shows it stood at $2.5 million in 2020, then skyrocketed by 650.16% to $18.4 million in 2021, then increased by 17.29% to $21.6 million in 2022, then crashed by 82.33% to $3.8 million in 2023, then surged by 258.84% to $13.7 million in 2024.
  • Per Business Quant database, its latest 3 readings for Accounts Payables were $13.7 million in Q4 2024, $2.9 million in Q3 2024, and $15.8 million in Q2 2024.